Invasively distinct subpopulations cooperate via a laminin-332/Rac1 axis in triple-negative breast cancer

被引:0
|
作者
Yoon, Sung Bo Joseph
Mouw, Janna
Chen, Luxiao
Wu, Hao
Marcus, Adam
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P6-14-01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-14-01
引用
收藏
页数:2
相关论文
共 50 条
  • [31] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [32] Expression of ERCC1 in triple-negative breast cancer
    Ozkan, C.
    Gumuskaya, B.
    Yaman, S.
    Aksoy, S.
    Guler, G.
    Altundag, M. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [34] Expression of MAS1 in triple-negative breast cancer
    Luo, Yi
    Kitadai, Yasuhiko
    Nishiguchi, Yukiko
    Fujiwara, Rina
    Sasaki, Takamitsu
    Ohmori, Hitoshi
    Kuniyasu, Hiroki
    CANCER RESEARCH, 2015, 75
  • [35] Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial
    Loap, Pierre
    Loirat, Delphine
    Berger, Frederique
    Rodrigues, Manuel
    Bazire, Louis
    Pierga, Jean-Yves
    Vincent-Salomon, Anne
    Laki, Fatima
    Boudali, Latifa
    Raizonville, Laurence
    Mosseri, Veronique
    Jochem, Anne
    Eeckhoutte, Alexandre
    Diallo, Mamadou
    Stern, Marc-Henri
    Fourquet, Alain
    Kirova, Youlia
    JAMA ONCOLOGY, 2022, 8 (12) : 1802 - 1808
  • [36] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [37] Role of ICAM-1 in triple-negative breast cancer
    Zhang, Ying
    Fan, Jingjing
    Wang, Xiaoli
    Wu, Zhongyu
    Ma, Weiqiang
    Ma, Binlin
    OPEN MEDICINE, 2024, 19 (01):
  • [38] A new therapeutic candidate for breast cancer: laminin-332 overexpressing myofibroblast formation via epithelial-mesenchymal transition in the interface zone
    Kim, Baek Gil
    Kang, Suki
    Cho, Nam Hoon
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 207 - 208
  • [39] Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer
    Inayatullah, Mohammed
    Mahesh, Arun
    Turnbull, Arran K.
    Dixon, J. Michael
    Natrajan, Rachael
    Tiwari, Vijay K.
    EMBO MOLECULAR MEDICINE, 2024, 16 (04) : 823 - 853
  • [40] Lactoferrin-Endothelin-1 Axis Contributes to the Development and Invasiveness of Triple-Negative Breast Cancer Phenotypes
    Ha, Ngoc-Han
    Nair, Vasudha S.
    Reddy, Divijendra Natha Sirigiri
    Mudvari, Prakriti
    Ohshiro, Kazufumi
    Ghanta, Krishna Sumanth
    Pakala, Suresh B.
    Li, Da-Qiang
    Costa, Luis
    Lipton, Allan
    Badwe, Rajendra A.
    Fuqua, Suzanne
    Wallon, Margaretha
    Prendergast, George C.
    Kumar, Rakesh
    CANCER RESEARCH, 2011, 71 (23) : 7259 - 7269